Interstitial Lung Disease is a Risk Factor for Cardiovascular Disease
Launched by ASSIUT UNIVERSITY · Aug 2, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how interstitial lung disease, specifically a condition called interstitial pulmonary fibrosis (IPF), might increase the risk of heart problems. Researchers at Assiut University Hospital are looking to recruit patients who have been diagnosed with IPF to learn more about how this lung condition can affect heart health. They will check for heart-related issues through various tests, including medical history reviews, heart rhythm tests (ECG), cholesterol levels, and heart ultrasound (echocardiography).
To be eligible for this study, you need to have a confirmed diagnosis of interstitial pulmonary fibrosis. The study aims to gather important information about your health, but participation is completely voluntary—if you choose not to join, that’s perfectly fine. If you decide to take part, you can expect a thorough assessment of your cardiovascular health, which may help in understanding the relationship between lung disease and heart problems better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed as Interstitial pulmonary fibrosis
- Exclusion Criteria:
- • Patients refusing to participate in the study
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Trial Officials
Waleed MD Gamal Elddin Khaleel, Ass. Prof.
Principal Investigator
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported